Seminars

April 20, 2020 update: CBR seminars have gone virtual! Please contact cbr.progasst@ubc.ca if you’re interested in attending the speaker talks.

 

2019/20 Seminar Series
Date Name Affiliation Title
Abstract Host
September 11, 2019 Dr. Paul S. Frenette Albert Einstein College of Medicine “Neutrophils, stress and sickle cell disease” Scott
September 25, 2019 Dr. Ze Zheng Columbia University Irving Medical Centre “Hepatocyte tPA: From Liver to Blood and Beyond” Conway
October 16, 2019 Dr. Eric Mullins Cincinnati Children’s Hospital Medical Centre “Should I Stay or Should I Go: Fibrin(ogen) and Fibrinolysis
in Neuroinflammation”
Kastrup
November 6, 2019 Dr. Doug Cines University of Pennsylvania “Defensins: Link between innate immunity, atherosclerosis and thrombosis” Kim
January 8, 2020 Dr. Kevin Hay BC Cancer Research Centre “CAR-T cell therapy: the experience and the road ahead” Conway
January 15, 2020 Dr. James Luyendyk College of Veterinary Medicine at MSU “Mechanisms linking blood coagulation to liver injury and
repair”
Conway
January 29, 2020 Dr. Lubica Rauova University of Pennsylvania “Heparin induced thrombocytopenia – therapeutic strategies alternative to anticoagulation.” Kizhakkedathu
February 5, 2020 Dr. Andrew Shih Vancouver General Hospital “What We Don’t Know About Massive Transfusion” Conway
February 12, 2020 Dr. Gary Gilbert Harvard Medical School  “Tales of factor VIII inhibitor antibodies: unexpected modulations by platelets and endothelial cells.” Conway
February 19, 2020 Dr. Timothy Nichols UNC School of Medicine “Novel Preclinical Approaches to Hemophilia A Complicated by Inhibitors” Kastrup
February 27, 2020 Dr. Sergio Martinez-Høyer Erasmus Medical Centre “Functional genomics in the pathogenesis of del(5q) myelodysplastic syndromes” Kastrup/Karsan
March 4, 2020 Dr. Colin Kretz McMaster University “High Throughput Protease Profiling to Investigate the Regulation of the Metalloprotease ADAMTS13” Conway
April 22, 2020 Dr. Ed Conway UBC “Complement activation: from atypical HUS to coronavirus-related disease”
April 29, 2020 Diana Canals & Dr. Michael Hughes UBC “Podocalyxin as a therapeutic target in cancer” & “Exploring an epigentic link between the gut microbiome and atopic disease”
May 6, 2020 Dr. Mark Scott UBC “Immunocamouflage: From Red Cells to Coronavirus”
May 13, 2020 Dr. Paul Jurasz University of Alberta “Identification of eNOS-based Platelet and Megakaryocyte Subpopulations”
May 20, 2020 Dr. Ed Pryzdial UBC “Antiviral Anticoagulation”
May 27, 2020 Dr. Leonard Foster UBC “Identification of unknown snake venom in a toddler”

June 3,

2020

Dr. Mona Khorshidfar UBC “Quality measurements of apheresis platelet concentrates from donors whose platelets repeatedly show low pH over storage”
June 10, 2020 Dr. Vijay Akhade UBC “miR-146a and p53 regulatory feedback loop in AML”
June 17, 2020 Dr. Christian Kastrup UBC “Natural and Novel Modulators of Blood Coagulation: From Soil Silicates in Hemorrhage to Gene Therapy for Thrombosis”

June 24,

2020

Dr. Dana Devine UBC “Convalescent Plasma as a therapy for treatment of COVID-19 disease”
July 8, 2020 Hancock Lab UBC “From the Outside-In: Treating Biofilm-Associated Infections with Synthetic Host Defence Peptides”
July 15, 2020 Dr. Hélène Côté & Anthony Hsieh UBC “HIV and aging – The CARMA cohort”
July 22, 2020 Ma Lab UBC “Image Based Cell Phenotyping Using AI” & “Deformability Based Sorting of Red Blood Cells as a Biomarker for Red Blood Cell Quality”

July 29,

2020

Brown Lab UBC “Hyaluronan primes the oxidative burst in human neutrophils: implications for inflammation”
August 19, 2020 Melina Messing & Marie-Soleil Smith UBC TBA
August 26, 2020 Dr. Jay Kizhakkedathu UBC TBA